Although evaluation of cardiac function with echocardiography has traditionally been limited to volume-based assessment, recent developments in cardiac ultrasound allow the noninvasive measurement of cardiac deformation with direct assessment of myocardial muscle by assessing regional Background-Fetal growth restriction (FGR) is associated with global adverse cardiac remodeling in utero and increased cardiovascular mortality in adulthood. Prenatal myocardial deformation has not been evaluated in FGR to date. We aimed to evaluate prenatal cardiac remodeling comprehensively in FGR including myocardial deformation imaging. Methods and Results-Echocardiography was performed in 37 consecutive FGR (defined as birthweight <10th centile) and 37 normally grown fetuses. A comprehensive fetal echocardiography was performed including tissue Doppler and 2-dimensional-derived strain and strain rate. Postnatal blood pressure measurement at 6 months of age was also performed. FGR cases showed signs of more globular hearts with decreased longitudinal motion (left systolic annular peak velocity: controls mean 6 cm/s [SD 1.2] versus FGR 5.3 [1]) and diastolic dysfunction (isovolumic relaxation time: controls 44 ms [6] versus FGR 52 [9]). Peak strain and strain rate values of the left ventricle were not significantly different; however, a postsystolic shortening in the basal segment of the septal ventricular wall was observed in 57% of the FGR cases and in none of controls (P<0.001). FGR cases with postsystolic shortening had absence of a hypertrophic response, a poorer perinatal outcome (lower gestational age and birthweight, containing all cases of perinatal mortality [8%]), and higher values of blood pressure. Conclusions-Myocardial deformation imaging revealed a postsystolic shortening in 57% of FGR, which supports increased pressure overload as a mechanism for cardiovascular programming in FGR. Postsystolic shortening was associated with severity and with higher blood pressure postnatally. (Circ Cardiovasc Imaging. 2014;7:781-787.)
F etal growth restriction (FGR) because of placental insufficiency affects 5% to 7% of pregnancies and represents one of the leading causes of perinatal morbidity and mortality. 1 Numerous historical cohort studies 2 and animal models 3 have demonstrated that FGR has a strong association not only with metabolic but also with primary cardiovascular remodeling that lead to long-term adverse consequences in later life. The rapid cell proliferation and differentiation during fetal growth are sensitive to any of the even smallest changes damaging the environment that can lead to permanent alterations in structural and functional constitution, which may persist into the adult life. 2 The heart is a central organ in the prenatal adaptation to placental insufficiency and fetal hypoxia. Previous studies have demonstrated remodeled hearts (more globular) with signs of systolic and diastolic dysfunction and preserved ejection fraction. [4] [5] [6] FGR cases are associated with prenatal adverse cardiac remodeling 4,5 that persists postnatally, 6 and low birth weight was linked to increased cardiovascular mortality in adulthood. 2 Chronic pressure/volume overload together with hypoxia in utero have been postulated as the potential underlying mechanistic pathway of prenatal cardiovascular remodeling in FGR. 5, 6 Editorial see p 759 Clinical Perspective on p 787 myocardial strain and strain rate. [7] [8] [9] Strain is defined as change in length/thickness of a segment of myocardium relative to its resting length and is expressed as a percentage; strain rate is the velocity of this deformation. [7] [8] [9] Myocardial deformation imaging has demonstrated a high sensitivity for detecting preclinical myocardial dysfunction in various pathological conditions characterized by myocardial dysfunction, despite preserved ejection fraction, such as asymptomatic carriers of hypertrophic cardiomyopathy, sarcomeric mutations, Fabry disease, or myocardial steatosis. 8 These techniques have been also be proven to be predictive of subsequent remodeling and functional recovery in coronary disease. 8 Despite strainderived measurements being recently validated for the fetal heart, 10-12 myocardial deformation has not been previously described in FGR. We conducted a case-control study in 37 FGR cases and controls where a comprehensive fetal echocardiography including strain-derived analysis was performed.
Methods

Study Populations
The study population included 37 FGR and 37 control pregnancies selected from women who attended BCNatal (Spain) from April 2009 to September 2012. FGR was defined by estimated fetal weight and birthweight below the 10th centile. 13 Controls were normally grown pregnancies frequency matched with cases by gestational age at scan (±2 weeks). The study protocol was approved by the local Ethics Committee, and patients provided their written informed consent. The study protocol included standard obstetric assessment together with comprehensive fetal echocardiography, record of perinatal data, and postnatal evaluation at 6 to 8 months of age including infants' height, weight, and blood pressure measurement.
Fetal Ultrasound
Fetal ultrasound was performed using a Siemens Sonoline Antares (Siemens Medical Systems, Malvern, PA) with 6-4 MHz linear curved array and 2 to 10 MHz phased array, together with a Vivid Q (General Electric Healthcare, Horten, Norway) with a phased array sector probe of 1.4 to 2.5 MHz for high frame rate 2-dimensional (2D) and color-coded tissue Doppler acquisitions. Standard fetoplacental ultrasound was performed at the time of FGR diagnosis including estimated fetal weight centile 13 and calculation of cerebroplacental ratio by dividing middle cerebral artery and umbilical artery pulsatility indeces. 14 Fetal echocardiography included a comprehensive examination to assess structural heart integrity, morphometry, function, and deformation analysis. No previous reports have assessed tissue Doppler or 2D strain in FGR, and therefore, as an exploratory study, we decided to evaluate both of them in this study. The heart and thoracic circumferences were measured at end diastole and expressed as a cardiothoracic ratio. 15 Ventricular sphericity indexes were calculated as base-to-apex length/basal diameter, measured from an apical 4-chamber view at end diastole. 16 Ventricular end-diastolic wall thicknesses were measured by M mode from a transverse 4-chamber view. 17 Left and right stroke volumes were calculated as π/4×(aortic/pulmonary valve diameter)2×(aortic/pulmonary artery systolic time-velocity integral). Then, left and right cardiac outputs were calculated as stroke volume×heart rate. 18 Left and right ventricular ejection fraction was obtained from M mode transverse 4-chamber views using the Teichholz formula. Longitudinal annular motion was assessed by M mode from an apical or basal 4-chamber view. 19 Spectral tissue Doppler was used to measure systolic (S′) and early diastolic (E′) annular peak velocities at mitral and tricuspid annuli from an apical or basal 4-chamber view. 20 Peak early and late transvalvular filling (E/A) ratios were estimated by calculating the ratio between early ventricular filling (E-wave) to late ventricular filling (A-wave) from atrioventricular flows obtained from a basal or apical 4-chamber view. Left isovolumetric relaxation time was measured from the closure of the aortic valve to the opening of the mitral valve. 21 Deformation analysis was performed off-line using GE Echo Pac PC SW 108.1.x (General Electric Healthcare, Horten, Norway) from color-coded tissue Doppler and 2D images (2D strain) as previously described. 10 An apical or basal 4-chamber view with the septum or free wall aligned parallel to the Doppler beam in 2D and 3 additional color tissue Doppler video clips were obtained from septum and left/ right free wall. If needed, a sector tilt was used to make sure that the angle between the probe and myocardial motion was <15%. No angle correction was applied off-line. The 2D scan area and tissue Doppler color box were kept as small as possible to obtain the highest frame rate. For each acquisition, 7.5 seconds of noncompressed data were stored in cine-loop format. Tissue Doppler off-line analysis of 10 to 13 cardiac cycles from 5 to 10 tissue Doppler sequences was performed following a standardized protocol 10 including manual indication of aortic valve closure and opening on the spectral aortic flow and also of mitral valve closure (as surrogate for the onset of the QRS complex in the ECG) in the clip to use it for timing events during the cardiac cycle in the absence of a real ECG. Longitudinal peak systolic strain and strain rate were calculated off-line and averaged for 5 consecutive heart cycles by placing a 2×3 mm sample area at the basal part of the septum and left/right ventricular free walls on the color tissue Doppler clip. Caution was taken that the sample area and strain length were within the myocardium in all phases of the cycle by reviewing, and correcting where needed, region placement frame by frame all along the analyzed cardiac cycles. Linear drift compensation was applied to the deformation curves, and only cycles with low drift compensation (<20%) were accepted as valid. Off-line deformation analysis from 2D grayscale cine-loops (2D strain) was performed following a standardized protocol 11 including the manual indication of aortic/mitral valve opening/closure as described above. Separately, both left and right ventricle's endocardial borders were manually traced on one arbitrary frozen frame that provided the best resolution of the endocardial border. The outer border was adjusted to approximate the epicardial border, and tracing width was kept at the minimum size in all cases. The software then provided a profile of longitudinal peak strain and strain rate for each segment together with the global deformation. Visual control of tracking quality was performed and, if required, optimized by adjusting the region of interest or manually correcting the contour to ensure adequate automatic tracking. Spatial and temporal smoothing were kept at 0% to assess visually the curves quality and then fixed at 50% to obtain the peak systolic strain and strain rate values at the basal left and right septal and free wall segments, as well as global strain and strain rate calculated as the average values of 6 segments for each ventricle.
Presence of In Utero Postsystolic Deformation
The presence postsystolic deformation (PSS), a known marker of pressure overload and ischemia, 7 was evaluated in the off-line 2D strain curve analysis and defined as shortening (of ≥10% of the systolic deformation) along the left ventricle long axis after closure of the aortic valve ( Figure) . 22, 23 It was assessed independently by 2 observers and defined as present only if both observers considered it positive. As an exploratory hypothesis-generating analysis, FGR cases were subdivided according to the presence of PSS for evaluating potential differences in perinatal, echocardiographic, and postnatal blood pressure results.
Statistical Analysis
Data were analyzed with IBM SPSS Statistics v19. Data are presented as mean (SD) or percentage, as appropriate. Characteristics of the study populations were compared by Student t test or χ 2 test. To evaluate the influence of covariates, comparisons of the fetal cardiovascular parameters among the study groups were adjusted for gestational age at scan, association with preeclampsia, and prenatal exposure to corticosteroids by linear (general linear model) regression. In the same manner, comparisons of the postnatal vascular parameters were adjusted for association with preeclampsia, prenatal exposure to corticosteroids, gestational age, and mode of delivery. In addition, an exploratory subanalysis was performed comparing baseline and cardiovascular parameters in FGR cases subdivided according to the presence of PSS using Student t test or χ 2 test. All reported P values are 2-sided. Fetal cardiovascular parameters are shown as crude values (main document) and also normalized into z scores or adjusted by heart size or estimated fetal weight (material in the Data Supplement).
Results
Characteristics of the Study Populations
Perinatal and postnatal characteristics of the study populations are shown in Table 1 . As expected, FGR cases presented a higher prevalence of perinatal complications with a lower gestational age at delivery, birthweight, and birthweight centile compared with controls. There were 3 cases of perinatal death in the group of FGR that were born at 25 to 26 weeks of gestation with low birthweight (400-550 g) and died in early neonatal period. At 6 to 8 months of age, FGR infants had lower height and weight compared with controls. Blood pressure was significantly increased in FGR compared with controls even after adjustment by preeclampsia, prenatal exposure to corticosteroids, gestational age, and mode of delivery (adjusted P=0.015 and 0.005 for systolic and diastolic blood pressure, respectively).
Fetal Ultrasound Assessment
Fetal standard ultrasound and echocardiographic results are shown in Table 2 . As expected, FGR cases had a lower estimated fetal weight centile at the time of exploration together with signs of placental insufficiency and redistribution (lower cerebroplacental ratio) compared with controls. Although ejection fraction and cardiac index were similar among the study groups, FGR cases showed a more dilated and globular heart (with increased cardiothoracic ratio and decreased right sphericity index) together with increased isovolumetric relaxation time and decreased longitudinal motion measured by tissue Doppler. FGR cases did not show significant mitral or tricuspid regurgitation. Deformation analysis using tissue Doppler and 2D strain analysis was possible in all fetuses with the exception of 2 FGR cases in which tissue Doppler acquisitions could not be adequately obtained because of oligohydramnios and fetal position. The mean frame rates were 182 fps (range, 151-235 fps) and 102 fps (73-161 fps) for tissue Doppler and 2D acquisitions, respectively. The mean frame rate/heart rates were 1.33 (1.02-1.8) and 0.80 (0.50-1.23) for tissue Doppler and 2D acquisitions, respectively. Global and regional peak strain and strain rate results were similar in the study populations. When analyzing the 2D derived data, the presence of PSS in the basal septum was noticed in 57% of FGR cases (21 of 37) and in none of the control pregnancies. We were not able to identify postsystolic shortening in tissue Doppler velocity curves.
Subanalysis in FGR Cases According to the Presence of PSS
Perinatal and cardiovascular results in FGR cases subdivided according to the presence of PSS are shown in Tables 3 and 4 . FGR cases with PSS showed a worse perinatal outcome with higher prevalence of preeclampsia, prenatal exposure to corticoids and respiratory distress syndrome together with more days of admission to the neonatal intensive care unit, and lower gestational age at delivery and Apgar score. All cases Data are mean (SD). 2D indicates 2-dimensional; A, ventricular inflow during atrial contraction; E, ventricular inflow in early diastole; E′, annular peak velocity in early diastole; FGR, fetal growth restriction; PSS, postsystolic shortening; and S′, systolic annular peak velocity. *P<0.05 compared with controls calculated by linear regression adjusted by gestational age at scan, prenatal exposure to corticoids, and presence of preeclampsia. 
Discussion
This study confirms the occurrence of in utero cardiac remodeling in FGR and demonstrates for the first time the presence of PSS prenatally. This finding supports the notion of increased pressure overload as a mechanism for cardiovascular programming in FGR.
In this study, we confirm previous reports showing signs of prenatal cardiac remodeling and dysfunction in FGR. FGR cases showed dilated and more globular hearts with preserved ejection fraction but signs of both systolic and diastolic dysfunction. These data are consistent with previous echocardiographic studies in fetuses and children with FGR. [4] [5] [6] In addition, to our knowledge, this is the first attempt to assess prenatal myocardial deformation in FGR. Most probably we could not demonstrate changes in longitudinal deformation parameters because of potential circumferential changes or the inherent higher noise levels in the measurements with tissue Doppler and speckle tracking being particularly challenging in the fetal heart with high heart rate and more motion. However, we noticed the presence of an abnormal strain curve in the basal septal region with PSS in more than half of FGR fetuses. Myocardial longitudinal shortening after aortic valve closure, termed PSS, has been well described in both experimental and clinical studies as a marker of myocardial functional adverse remodeling, mainly in the setting of acute ischemia and pressure overload in adulthood. [22] [23] [24] [25] The sign has been attributed to unbalanced contractility or loading in neighboring myocardial segments. 26 Given the geometry of the left ventricle, the highest pressure loading can be expected in the basal septal segment because of the local anatomic larger radius of curvature compared with the lateral free wall or the apex. If not counterbalanced by the pressure generated in the other ventricle, this can lead to a local increase in wall stress and the development of PSS. Therefore, when left or right ventricular pressure overload occurs, and the local tissue has not increased its contractility and thickness (myocardial hypertrophy), the increase in wall stress because of pressure loading cannot be compensated and thus leads to an abnormal septal deformation. 26 Although all FGR cases showed signs of in utero cardiac remodeling, FGR cases with PSS showed a more prominent myocardial dysfunction (in same region as the PSS) with no signs of hypertrophy compared with FGR cases without PSS. In addition, the highest values of postnatal blood pressure were measured in the FGR infants who had prenatal PSS. Thus, we think that the presence of PSS suggests chronic pressure overload associated with the inability, or the shorten of time in case of rapidly increasing placental dysfunction, to induce a myocardial hypertrophic response in the most severe FGR cases. These results are consistent with experimental studies demonstrating in utero hypertension in FGR 27 and also with previous literature in hypertensive adults presenting PSS. 23, 25 A worse perinatal outcome was observed in FGR cases with PSS. The presence of PSS could indeed reflect a more severe degree of placental insufficiency and poorer fetal hemodynamic status without appropriate physiological hypertrophic adaptation. The underlying pathophysiology of FGR is complex with placental insufficiency, leading to fetal undernutrition and hypoxia together with a variable degree of pressure and volume overload. The milder cases of placental insufficiency may be able to compensate by hypertrophy, thus PSS is not present. Conversely, the most severe cases of placental insufficiency are supposed to have a higher degree of undernutrition and hypoxia that may prevent the myocardium to hypertrophy, leading to an incompetence to compensate pressure overload and displaying PSS. This supports the use of PSS as a potential marker of prenatal disease severity and to monitor these fetuses. Other fetal cardiovascular parameters such as ductus venosus have previously demonstrated its use in predicting poor perinatal outcome 28, 29 and are already being used in clinical practice for monitoring FGR. 28 On top of its correlation with perinatal results, the presence of PSS was also associated to postnatal blood pressure values. This finding is consistent with PSS being an early marker of hypertension in the adult 23, 25 and also with recent data suggesting a strong correlation between fetal echocardiographic parameters and hypertension in infancy. 30 From a clinical perspective, this study opens opportunities to find new applications for echocardiography in fetal life because it might help identifying FGR cases at high cardiovascular risk later in life. Considering the high prevalence of FGR, it is of utmost clinical relevance to detect cardiovascular risks as early as possible to introduce timely preventive interventions and to adapt the lifestyle to improve the long-term cardiovascular health outcome and the quality of life of FGR children. Overall, the potential use of PSS as a marker of perinatal outcome and postnatal hypertension is warranted in future studies.
This study has several strengths and limitations. Fetal heart evaluation is challenging because of the smallness and high heart rate of the fetus, as well as the restricted access to the fetus far from the transducer. Despite these limitations, evaluation of cardiac function has demonstrated to be feasible and reproducible in most fetuses when performed with appropriate ultrasound equipment following strict methodological criteria. 10 In this study, fetal echocardiographic parameters including strainderived indices were measured following a strict methodology with high frame rate acquisitions. To overcome the impossibility of fetal ECG coregistration, manual indication of time events based on the underlying 2D images was performed. 11 In the fetal FGR heart, with the current strain technology, we are not able to demonstrate a significant change in longitudinal strain. Our assumption is that the muscle is still less differentiated toward its final fiber structure and that these fibres are still dynamic to remodel in such a way as to maintain the (more efficient) longitudinal deformation. It could be also explained by the inherent higher noise levels in the measurements with tissue Doppler and speckle tracking being particularly challenging in the fetal heart with high heart rate and more motion. Although strain analysis might be cumbersome in daily clinical practice, in future studies, the presence of PSS can also be detected using (anatomic) M mode imaging in the basal septum. We also acknowledge the limited sample size of this study limiting the confidence of some conclusions, particularly comparisons between FGR subdivided according PSS that are mainly exploratory hypothesisgenerating analyses. Radial/circumferential strain could not be assessed with the postnatal persistence of PSS remaining to be demonstrated. Despite the analysis being adjusted for potential influences, we acknowledge that other confounders could have interfered our results.
In conclusion, FGR shows global adverse cardiac remodeling and regional abnormalities in deformation similar to what has been described in hypertension. The presence of PSS in FGR is associated with worse perinatal and cardiovascular outcomes and provides a potential mechanistic pathway and diagnostic tool to monitor and potentially to interfere with cardiac programming.
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